日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM)

一项多中心、开放标签、单臂 II 期试验,旨在评估使用 3% 聚多卡醇泡沫硬化疗法治疗二度痔疮的疗效和安全性 (SCLEROFOAM)

Gallo, G; Pietroletti, R; Novelli, E; Sturiale, A; Tutino, R; Lobascio, P; Laforgia, R; Moggia, E; Pozzo, M; Roveroni, M; Bianco, V; Luc, A Realis; Giuliani, A; Diaco, E; Naldini, G; Trompetto, M; Perinotti, R; Sammarco, G

Mesoglycan for pain control after open excisional HAEMOrrhoidectomy (MeHAEMO): an observational multicentre study on behalf of the Italian Society of Colorectal Surgery (SICCR)

美索聚糖用于开放式切除性 HAEMO 痔疮切除术后疼痛控制(MeHAEMO):一项代表意大利结直肠外科协会 (SICCR) 的观察性多中心研究

Gallo, G; Di Saverio, S; Clerico, G; Sturiale, A; Manigrasso, M; Luc, A Realis; Trompetto, M; Sammarco, G

Correction to: Mesoglycan for pain control after open excisional HAEMOrrhoidectomy (MeHAEMO): an observational multicentre study on behalf of the Italian Society of Colorectal Surgery (SICCR)

更正:Mesoglycan 用于开放式切除 HAEMO 痔疮术后疼痛控制 (MeHAEMO):一项代表意大利结直肠外科协会 (SICCR) 的观察性多中心研究

Gallo, G; Di Saverio, S; Clerico, G; Sturiale, A; Manigrasso, M; Luc, A Realis; Trompetto, M; Sammarco, G